• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ST段抬高型心肌梗死中白细胞计数与梗死面积的相关性

Correlation between leukocyte count and infarct size in ST segment elevation myocardial infarction.

作者信息

Ferrari Júlia Peixoto, Lueneberg Maria Emília, da Silva Roberto Leo, Fattah Tammuz, Gottschall Carlos Antônio Mascia, Moreira Daniel Medeiros

机构信息

Universidade do Sul de Santa Cataria - Unisul, Palhoça, Brazil.

Instituto de Cardiologia de Santa Catarina - ICSC, São José, Brazil.

出版信息

Arch Med Sci Atheroscler Dis. 2016 Jun 21;1(1):e44-e48. doi: 10.5114/amsad.2016.60759. eCollection 2016.

DOI:10.5114/amsad.2016.60759
PMID:28905018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5421522/
Abstract

INTRODUCTION

Regarding the inflammatory mechanisms involved in ischemic heart disease, currently the leukocyte count is the subject of studies related to its association with the prognosis and mortality of ST segment elevation myocardial infarction (STEMI). Our aim is correlate the leukocyte count rise with the size of STEMI, evaluated with the area under the curve (AUC) and the peak of necrosis markers release.

MATERIAL AND METHODS

This study is a sub-analysis of the TETHYS trial, a clinical trial that evaluated the effects of methotrexate in STEMI. We evaluated the correlation between quantitative variables with Pearson's correlation, and the variables that did not follow a normal distribution were subjected to logarithmic transformation to base 10. The value of < 0.05 indicated statistical significance.

RESULTS

Males accounted for 73% of the participants, who had an average age of 59 years. A total of 58% were hypertensive and 53% smokers. The leukocyte count at hospital admission was significantly correlated with the AUC creatine kinase (CK) ( = 0.256, = 0.021), troponin AUC ( = 0.247, = 0.026), peak CK ( = 0.270, = 0.015) and troponin peak ( = 0.233, = 0.037). The leukocyte count at 72 h was significantly correlated with CK AUC ( = 0.238, = 0.032), AUC of MB portion of CK ( = 0.240, = 0.031) and peak CK ( = 0.224, = 0.045).

CONCLUSIONS

White blood cell count correlates with STEMI size assessed by serial cardiac biomarker levels.

摘要

引言

关于缺血性心脏病所涉及的炎症机制,目前白细胞计数是与ST段抬高型心肌梗死(STEMI)的预后和死亡率相关研究的主题。我们的目的是将白细胞计数升高与STEMI的大小相关联,通过曲线下面积(AUC)和坏死标志物释放峰值进行评估。

材料与方法

本研究是TETHYS试验的一项亚分析,TETHYS试验是一项评估甲氨蝶呤对STEMI疗效的临床试验。我们用Pearson相关性评估定量变量之间的相关性,对不服从正态分布的变量进行以10为底的对数转换。P<0.05表示具有统计学意义。

结果

男性占参与者的73%,平均年龄为59岁。共有58%的人患有高血压,53%的人吸烟。入院时白细胞计数与肌酸激酶(CK)的AUC显著相关(r = 0.256,P = 0.021)、肌钙蛋白AUC(r = 0.247,P = 0.026)、CK峰值(r = 0.270,P = 0.015)和肌钙蛋白峰值(r = 0.233,P = 0.037)。72小时时白细胞计数与CK的AUC显著相关(r = 0.238,P = 0.032)、CK的MB部分的AUC(r = 0.240,P = 0.031)和CK峰值(r = 0.224,P = 0.045)。

结论

白细胞计数与通过系列心脏生物标志物水平评估的STEMI大小相关。

相似文献

1
Correlation between leukocyte count and infarct size in ST segment elevation myocardial infarction.ST段抬高型心肌梗死中白细胞计数与梗死面积的相关性
Arch Med Sci Atheroscler Dis. 2016 Jun 21;1(1):e44-e48. doi: 10.5114/amsad.2016.60759. eCollection 2016.
2
MethotrexaTE THerapy in ST-Segment Elevation MYocardial InfarctionS: A Randomized Double-Blind, Placebo-Controlled Trial (TETHYS Trial).甲氨蝶呤治疗ST段抬高型心肌梗死:一项随机双盲、安慰剂对照试验(特提斯试验)
J Cardiovasc Pharmacol Ther. 2017 Nov;22(6):538-545. doi: 10.1177/1074248417699884. Epub 2017 Mar 22.
3
Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial).前壁ST段抬高型急性心肌梗死患者左心室质量与梗死面积的关系(来自EMBRACE STEMI临床试验)
Am J Cardiol. 2016 Sep 1;118(5):625-31. doi: 10.1016/j.amjcard.2016.06.025. Epub 2016 Jun 15.
4
Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.急性心肌梗死后行直接经皮冠状动脉介入治疗患者的峰值心脏肌钙蛋白 T 水平、闪烁心肌梗死面积与 1 年预后。
Am J Cardiol. 2010 Nov 1;106(9):1212-7. doi: 10.1016/j.amjcard.2010.06.050. Epub 2010 Sep 9.
5
The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.ST段抬高型心肌梗死后肌酸激酶同工酶峰值相对于其他临床和血管造影特征在预测梗死面积、左心室射血分数及死亡率方面的当代价值。
Clin Cardiol. 2017 May;40(5):322-328. doi: 10.1002/clc.22663. Epub 2016 Dec 27.
6
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction.在ST段抬高型心肌梗死情况下,梗死面积的酶学评估与功能及临床结局相关。
Curr Control Trials Cardiovasc Med. 2005 Aug 23;6(1):12. doi: 10.1186/1468-6708-6-12.
7
Comparison of Troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty.对接受直接血管成形术的ST段抬高型心肌梗死患者,肌钙蛋白T与肌酸激酶及放射性核素心脏成像梗死面积的比较。
Am J Cardiol. 2008 Mar 15;101(6):753-7. doi: 10.1016/j.amjcard.2007.09.119. Epub 2008 Jan 14.
8
Rationale and design of the TETHYS trial: the effects of methotrexate therapy on myocardial infarction with ST-segment elevation.TETHYS试验的原理与设计:甲氨蝶呤治疗对ST段抬高型心肌梗死的影响
Cardiology. 2013;126(3):167-70. doi: 10.1159/000351972. Epub 2013 Aug 30.
9
Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial).肌酸激酶同工酶MB峰值测量在预测首次前壁急性心肌梗死患者的心肌梗死面积、左心室功能障碍及预后中的应用(来自INFUSE-AMI试验)
Am J Cardiol. 2015 Mar 1;115(5):563-70. doi: 10.1016/j.amjcard.2014.12.008. Epub 2014 Dec 18.
10
Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy.肌酸激酶同工酶分析方法预测接受再灌注治疗的心肌梗死患者的死亡率。
Trials. 2013 May 2;14:123. doi: 10.1186/1745-6215-14-123.

引用本文的文献

1
Red Blood Cell, White Blood Cell, and Platelet Counts as Differentiating Factors in Cardiovascular Patients with and Without Current Myocardial Infarction.红细胞、白细胞和血小板计数作为区分有无当前心肌梗死的心血管疾病患者的因素
Int J Mol Sci. 2025 Jun 15;26(12):5736. doi: 10.3390/ijms26125736.
2
Type 2 diabetes worsens the outcome of ischemia/reperfusion in female STEMI patients and female db/db mice with HFpEF cardiometabolic phenotype.2型糖尿病会使患有射血分数保留的心力衰竭(HFpEF)心脏代谢表型的女性ST段抬高型心肌梗死(STEMI)患者和雌性db/db小鼠的缺血/再灌注结果恶化。
Cardiovasc Diabetol. 2025 Jun 7;24(1):243. doi: 10.1186/s12933-025-02771-z.
3
Elevated Leukocyte Count and Platelet-Derived Thrombogenicity Measured Using the Total Thrombus-Formation Analysis System in Patients with ST-Segment Elevation Myocardial Infarction.ST 段抬高型心肌梗死患者采用全血栓形成分析系统检测白细胞计数和血小板衍生的血栓形成能力升高。
J Atheroscler Thromb. 2024 Sep 1;31(9):1277-1292. doi: 10.5551/jat.64395. Epub 2024 Mar 6.
4
Reperfusion Cardiac Injury: Receptors and the Signaling Mechanisms.再灌注心脏损伤:受体和信号转导机制。
Curr Cardiol Rev. 2022;18(5):63-79. doi: 10.2174/1573403X18666220413121730.

本文引用的文献

1
Rationale and design of the TETHYS trial: the effects of methotrexate therapy on myocardial infarction with ST-segment elevation.TETHYS试验的原理与设计:甲氨蝶呤治疗对ST段抬高型心肌梗死的影响
Cardiology. 2013;126(3):167-70. doi: 10.1159/000351972. Epub 2013 Aug 30.
2
Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial).白细胞计数、死亡率与非 ST 段抬高型急性冠状动脉综合征患者出血的相关性(来自急性血管成形术和紧急介入治疗策略试验)。
Am J Cardiol. 2013 May 1;111(9):1237-45. doi: 10.1016/j.amjcard.2012.12.056. Epub 2013 Feb 11.
3
Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.白细胞在动脉粥样硬化、心肌梗死和心力衰竭中的作用。
Science. 2013 Jan 11;339(6116):161-6. doi: 10.1126/science.1230719.
4
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.《2013年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2013 Jan 1;127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad. Epub 2012 Dec 12.
5
Cardiovascular disease. Massive trials to test inflammation hypothesis.心血管疾病。检验炎症假说的大规模试验。
Science. 2012 Sep 7;337(6099):1158. doi: 10.1126/science.337.6099.1158.
6
Inflammation in coronary artery disease and acute myocardial infarction - is the stage set for novel therapies?在冠状动脉疾病和急性心肌梗死中的炎症——为新型疗法奠定了基础?
Curr Pharm Des. 2012;18(28):4358-69. doi: 10.2174/138161212802481219.
7
Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing.心肌梗死后愈合中的抗炎机制和治疗机会。
J Mol Med (Berl). 2012 Apr;90(4):361-9. doi: 10.1007/s00109-011-0847-y. Epub 2012 Jan 7.
8
Anti-inflammatory Agents: Present and Future.抗炎药:现状与未来。
Cell. 2010 Mar 19;140(6):935-50. doi: 10.1016/j.cell.2010.02.043.
9
The effects of METhotrexate therapy on the physical capacity of patients with ISchemic heart failure: a randomized double-blind, placebo-controlled trial (METIS trial).甲氨蝶呤治疗对缺血性心力衰竭患者身体能力的影响:一项随机、双盲、安慰剂对照试验(METIS 试验)。
J Card Fail. 2009 Dec;15(10):828-34. doi: 10.1016/j.cardfail.2009.06.439. Epub 2009 Aug 5.
10
The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction.细胞外基质作为心肌梗死后炎症和修复反应的调节剂。
J Mol Cell Cardiol. 2010 Mar;48(3):504-11. doi: 10.1016/j.yjmcc.2009.07.015. Epub 2009 Jul 23.